Efficacy and Safety of the CollaRx Bupivacaine Implant Compared to the ON-Q Painbuster Following Abdominal Hysterectomy
Status:
Completed
Trial end date:
2008-12-22
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the CollaRx Bupivacaine Implant is safe and
effective in reducing the amount of narcotic pain medication needed to control pain during
the first 96 hours after abdominal hysterectomy when compared to the ON-Q PainBuster Post-op
Pain Relief System.